Chain Drug Review - Mylan Approval
PITTSBURGH — Mylan Laboratories Inc. has received approval from the FDA to manufacture and market terazosin hydrochloride capsules, the generic equivalent to Abbott Laboratories’ Hytrin.
Related Results
Common prostate drug is ineffective - Hytrin works better - Hytrin vs ProscarMylan receives approval for generic HytrinTorPharm Hytrin ANDA clearedTrust, E-innovation and Leadership in ChangeForeign Banks in United States Since World War II: A Useful Fringe
COPYRIGHT 2000 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
